Shayna Sarosiek, Md

This study is testing whether the drug pacritinib is safe and effective for people with Waldenström macroglobulinemia, a rare blood cancer, that has come back or stopped responding to other treatments. About 30 participants will take the oral drug daily for up to four years to se…